Trial Profile
Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Apr 2012
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Vatalanib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 30 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Mar 2012 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
- 03 Jun 2009 New trial record.